Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Proteon Pharmaceuticals

Explore full profile

Uses precision biology for microbiome protection to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics

Łódź, PolandFounded 2005Biotech & Life Sciences
Valuation $100–250M Last recorded · 2021
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Proteon Pharmaceuticals and the history behind them.

About Proteon Pharmaceuticals

Proteon Pharmaceuticals leverages precision biology to develop microbiome protection solutions aimed at improving animal and human health. Operating in the animal health sector, the company partners with farmers to enhance the economic efficiency of farms through environmentally sustainable and natural solutions. Proteon's core products include feed additives that prevent and eliminate infections in poultry and aquaculture, thereby reducing the need for antibiotics. The company employs advanced technologies such as bioinformatics, Artificial Intelligence, genomic sequencing, materials engineering, and molecular biology in its proprietary Phage Development Platform. This platform has been refined over more than a decade of research and development in bacteriophages, which are viruses that target and destroy specific bacteria. By focusing on precision-targeted solutions, Proteon aims to address the overuse of antibiotics in livestock farming, which is a significant concern for both animal and human health. The business model involves partnering with farmers and distributors to deliver these innovative solutions, generating revenue through product sales and strategic partnerships.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
Łódź, Poland
Employees
49
Open positions
None listed
Dealroom signal
59.9/100
Industry
Health
Sub-industry
BioTechnology, AgriTech
Sector
Biotech & Life Sciences, Aquaculture, Biotechnology, Poultry, Sustainable Development Goals, Dairy Farming, Biotech and Pharma, Climate Tech, Blue Economy, Blue Biotechnology
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Aug 2021 $23M $92M Aqua-Spark · Montis Capital · Polish Development Fund - PFR · Seventure Partners —
SERIES A✓Equity / VC Jan 2020 $10M $42M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Proteon Pharmaceuticals website traffic

Latest recorded traffic for Proteon Pharmaceuticals is 470 monthly website visits, down 66.4% over the last three months. Proteon Pharmaceuticals's team declined 32.9% over the past year.

Latest monthly visits470 3-month web change-66.4% 1-year team growth-32.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
ResistomapEnvironmental surveillance of antibiotic resistance using genetic data. Helsinki, Finland Operational 16 $2.2M $8.8M
Canadian Pacifico Seaweeds Ltd.Provides consultation and farmer support throughout all phases of farming development from site selection and design to deployment and maintenance Surrey, Canada Operational
Alginor ASAAlginor's green innovation, AORTA, increases the utilisation ratio of seaweeds from approximately 15 to 100% without using formaldehyde and other harmful chemicals Haugesund, Norway Operational
ScotBioPatented indoor cultivation of natural food colorants Livingston, United Kingdom Operational
ALGAIAIs a company developing, producing and commercializing Natural Extracts, mostly made out of seaweed Lannilis, France Acquired
TransAlgaeDevelops an algae-based platform for oral delivery of high value products for Animal Health and Crop Protection Rehovot, Israel Operational
Simris AlgA biotechnology company, engaged in research, development, and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical, and pharmaceutical applications Simrishamns kommun, Sweden Operational
HolloidProvides real-time multi-dimensional data on colloids, based on 3D imaging, with the throughput of cytometry Vienna, Austria Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Aqua-Spark
  • Montis Capital
  • Polish Development Fund - PFR
  • Seventure Partners
  • Nutreco

Other known investors3 additional known investors

  • 1000 Ocean Startups
  • KU Innovation Park
  • Newtree Impact
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇵🇱 Poland85.3%
🇮🇳 India8.8%
🇺🇸 United States2.9%
🇧🇷 Brazil2.9%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Proteon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Proteon Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.